OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.
By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.
Vasoactive Intestinal Peptide, Aviptadil. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: clinical.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Low reported | 50 mcg | up to 4× daily | 0.05 mL | 5 u | 200 doses | |
| Upper reported | 100 mcg | up to 4× daily | 0.1 mL | 10 u | 100 doses | |
| Trial dose | up to 150 pmol/kg/h weight-based | 12 h ×3 days | Set by body weight — can't be turned into a single amount to draw | |||
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial | |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 50 mcg | daily | 0.05 mL | 5 u | 14 | 0.7 mg |
| Week 3 onward per 4 weeks from here on |
100 mcg | daily | 0.1 mL | 10 u | 28 | 2.8 mg |
A 28-amino-acid neuropeptide with vasodilatory and immunomodulatory activity. The aviptadil formulation reached large registered trials in respiratory failure. Use in chronic inflammatory response syndrome is far less well evidenced. Hypotension is a real risk.
Buy VIPthis peptideOpens optimal-pep.com in a new tab
Browse the full catalogue, or jump to a neighbouring compound.
A thymic peptide approved in a number of countries as an immunomodulator, principally as adjunct therapy in chronic hepatitis B an…
A p53-derived peptide fused to a membrane-penetrating sequence, reported to selectively lyse cancer cell membranes in vitro and in…
Every compound compared in one table: dose range, how often, half-life and evidence tier.